GlucoTrack (NASDAQ:GCTK) Upgraded at Wall Street Zen

Wall Street Zen upgraded shares of GlucoTrack (NASDAQ:GCTK) from a strong sell rating to a sell rating in a research report released on Saturday morning.

Separately, Weiss Ratings reaffirmed a “sell (e+)” rating on shares of GlucoTrack in a research report on Friday, July 17th. One analyst has rated the stock with a Sell rating, According to data from MarketBeat.com, GlucoTrack currently has an average rating of “Sell”.

GlucoTrack Stock Performance

Shares of GCTK stock opened at $0.40 on Friday. The company has a debt-to-equity ratio of 0.08, a current ratio of 0.85 and a quick ratio of 0.85. The firm has a 50-day moving average of $0.42 and a 200-day moving average of $0.96. GlucoTrack has a one year low of $0.25 and a one year high of $14.14. The company has a market cap of $3.11 million, a P/E ratio of -0.02 and a beta of 0.70.

Institutional Investors Weigh In On GlucoTrack

A number of hedge funds have recently made changes to their positions in GCTK. Ikarian Capital LLC bought a new stake in GlucoTrack in the fourth quarter worth about $177,000. Boothbay Fund Management LLC purchased a new stake in shares of GlucoTrack during the 4th quarter worth approximately $52,000. Finally, Bank of America Corp DE raised its holdings in shares of GlucoTrack by 102,125.0% in the 2nd quarter. Bank of America Corp DE now owns 4,089 shares of the company’s stock worth $25,000 after purchasing an additional 4,085 shares during the period. 10.92% of the stock is currently owned by institutional investors.

GlucoTrack Company Profile

GlucoTrack, Inc, a medical device company, focused on the design, development, and commercialization of novel technologies for people with diabetes in the United States. It develops GlucoTrack, a noninvasive glucose monitoring device that helps people with diabetes and pre-diabetics to obtain blood glucose level readings without the pain. The company was formerly known as Integrity Applications, Inc and changed its name to GlucoTrack, Inc in November 2021. GlucoTrack, Inc was founded in 2001 and is based in Rutherford, New Jersey.